JESSICA CANAAN: Open Payments
NPI 1164044327 · HAMPSTEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 64 payments from 16 companies in 2025. Trend: 2023 $363 · 2024 $783 · 2025 $1,606
Food & beverage: $1,448Education: $141Consulting: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $526 |
| ARS Pharmaceuticals Operations, Inc. | 15 | $330 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| BioCryst US Sales Co., LLC | 4 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Genentech USA, Inc. | 3 | $72 |
| Azurity Pharmaceuticals, Inc. | 3 | $67 |
| CSL Behring | 2 | $49 |
| Seqirus USA Inc | 2 | $41 |
| Amgen Inc. | 2 | $36 |
Products named: DUPIXENT, NEFFY, ORLADEYO, TEZSPIRE, EOHILIA, Xolair, ALVESCO, Andembry.
Industry payments across NC — which companies pay providers there.
